Press Releases
At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
4353
-
-
François de Varenne Biography
documentSeptember 7, 2016 — 00:00 -
Paolo de Martin Biography
documentSeptember 7, 2016 — 00:00 -
At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
documentSeptember 7, 2016 — 00:00 -
Download this file named : SCOR launches its new strategic plan, “Vision in Action” - German version
German version - At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
documentSeptember 7, 2016 — 00:00 -
Denis Kessler Biography
documentSeptember 7, 2016 — 00:00 -
Frieder Knüpling Biography
documentSeptember 7, 2016 — 00:00 -
On the proposal of its committee members in charge of nominations, SCOR’s Board of Directors has unanimously decided to propose, at the Combined Shareholders’ Meeting of 27 April 2017, the renewal of Denis Kessler’s d
documentSeptember 7, 2016 — 00:00 -
Expert viewsAugust 30, 2016
Alexander Fleming’s discovery of Penicillin in 1928 marked one of the proudest achievements of 20th Century medicine. A decade of R&D later and suddenly mankind had the ability to fight a whole class of diseases.
-
Press ReleasesThe redemption of the two debts was already prefinanced.
-
The redemption of the two debts was already prefinanced
documentAugust 4, 2016 — 00:00 -
Press Releases
SCOR completed the calls of the entire balance of its EUR 350 million and CHF 650 million undated subordinated note lines on 28 July and 2 August 2016 respectively.
